Posted in | News | Business | Chemistry

Praxair to Double Production Capacity of Tennessee-Based Air Separation Complex

Praxair, one of the largest industrial gas companies in the world, plans to expand its air separation plant in Memphis, Tennessee.

This capacity expansion will support production and delivery of nitrogen and oxygen gases to Valero Energy and Nucor. Praxair will add a new manufacturing capacity capable of producing 400 tons of liquid per day. The planned extension supports the company to meet the rising customer needs.

Recently, the company constructed a pipeline for serving the Riverport area customers. Praxair is planning for a new facility in the third quarter of 2011. Praxair’s VP of the East Region, Kevin Foti states that air separation complexes of the company provides continuous reliability, quality and operational efficiencies for meeting the present and future customer needs. The global supplier of industrial gases seeks to expand its relationship with Valero Energy, a global manufacturer and distributor of petrochemical products, and Nucor, a manufacturer of steel products. This might contribute to Praxair’s steady growth in the Southeast market.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Praxair to Double Production Capacity of Tennessee-Based Air Separation Complex. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=28416.

  • MLA

    Chai, Cameron. "Praxair to Double Production Capacity of Tennessee-Based Air Separation Complex". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=28416>.

  • Chicago

    Chai, Cameron. "Praxair to Double Production Capacity of Tennessee-Based Air Separation Complex". AZoM. https://www.azom.com/news.aspx?newsID=28416. (accessed November 22, 2024).

  • Harvard

    Chai, Cameron. 2019. Praxair to Double Production Capacity of Tennessee-Based Air Separation Complex. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=28416.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.